Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway.
Hu K, Li B, Ma R, Yi H, Xu Z, Peng Y, Yu D, Wu H, Cheng T, Lu Y, Zhang Y, Wei R, Yang G, Wu X, Zhu W, Shi J.
Hu K, et al. Among authors: peng y.
Acta Biochim Biophys Sin (Shanghai). 2021 Apr 15;53(5):575-583. doi: 10.1093/abbs/gmab031.
Acta Biochim Biophys Sin (Shanghai). 2021.
PMID: 33821934
Free article.